The increase was largely attributed to VYVGART’s performance, along with other products like ZEJULA and NUZYRA. Additionally, Zai Lab reported a net loss improvement, reflecting efforts in financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback